UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037042
Receipt No. R000042187
Scientific Title The effect of the algae food intake on athletes immunity Open study
Date of disclosure of the study information 2020/06/12
Last modified on 2020/06/12 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of the algae food intake on athletes immunity
Open study
Acronym The effect of the algae food intake on athletes immunity
Scientific Title The effect of the algae food intake on athletes immunity
Open study
Scientific Title:Acronym The effect of the algae food intake on athletes immunity
Region
Japan

Condition
Condition Healthy individual
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of the algal food intake to athlete immunity
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes secretory immunoglobulin A
Key secondary outcomes Body composition, Subjective evaluation (Feeling of Fatigue, Feeling)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 To intake algal food
Interventions/Control_2 Not to intake algal food
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
40 years-old >
Gender Male
Key inclusion criteria (1)Healthy man who are 20 or more to less than 40 years old
(2)Healthy people who are not currently treating any visceral disease
(3)Those from whom a written consent can be obtained on a voluntary basis
Key exclusion criteria (1)Individuals using medical products
(2)Individuals who are prone to allergies for foods
(3)Individiuals who has a history of serious disease / current illness
(4)Individiuals who has a history of alcohol and drug addiction
(5)Individiuals who is unsuitable for the entry judged by a officer
Target sample size 24

Research contact person
Name of lead principal investigator
1st name Madoka
Middle name
Last name Takahashi
Organization KOBELCO ECO-SOULUTIONS CO.,LTD
Division name Technical Develop Center
Zip code 651-2241
Address 1-1-4, Murotani, Nishi-ku, Kobe 651-2241
TEL 078-992-6957
Email md.takahashi@kobelco-eco.co.jp

Public contact
Name of contact person
1st name Madoka
Middle name
Last name Takahashi
Organization KOBELCO ECO-SOULUTIONS CO.,LTD
Division name Technical Develop Center
Zip code 651-2241
Address 1-1-4, Murotani, Nishi-ku, Kobe 651-2241
TEL 078-992-6957
Homepage URL
Email md.takahashi@kobelco-eco.co.jp

Sponsor
Institute KOBELCO ECO-SOULUTIONS CO.,LTD
Institute
Department

Funding Source
Organization KOBELCO ECO-SOULUTIONS CO.,LTD
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The ethical committee of the Hokubukai Group Utukushigaoko Hospital
Address 61-1, Shinei, Kiyota-ku, Sapporo, 004-0839, Japan
Tel 011-882-0111
Email wakimoto@ughp-cpc.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 24
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 05 Month 28 Day
Date of IRB
2019 Year 05 Month 29 Day
Anticipated trial start date
2019 Year 06 Month 13 Day
Last follow-up date
2019 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 06 Month 12 Day
Last modified on
2020 Year 06 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042187